Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
CURIS INC
Curis, Inc. has scheduled a special meeting of stockholders for November 18, 2026, to vote on a proposal to effect a reverse stock split of its common stock. The board of directors will determine the final ratio, ranging from 1-for-5 to 1-for-12, and shareholders will also vote on a proposal to adjourn the meeting if necessary.…more
CURIS INC
Curis has entered into a securities purchase agreement to raise approximately $8.5 million through the issuance of common stock and warrants. The proceeds will be used for research and development and working capital, providing sufficient funding to support operations through the release of initial Chronic Lymphocytic Leukemia (CLL) clinical data in December 2026.…more
CURIS INC
Curis Inc received official notice of effectiveness from the SEC for its registration statement on August 12, 2026. This approval allows the company to proceed with the issuance of securities and related capital raising activities.…more
4 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
Curis Announces $8.5M Common Stock and Warrant Offering
Curis has entered into agreements to raise approximately $8.5 million through the sale of common stock and warrants. The issuance of new shares and warrants is expected to result in shareholder dilution.…more